Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Wolf

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Chemistry|September 6, 2008
Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumorsMaria Bujalkova, Katarina Zavodna, Tomas Krivulcik, et al.
The Journal of General Virology|November 14, 2013
Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vectorIrina Kuznetsova, Anna-Polina Shurygina, Brigitte Wolf, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 20, 2014
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group studyDaniela Kandioler, Sebastian F Schoppmann, Ronald Zwrtek, et al.
Neoplasia (New York, N.Y.)|December 18, 2019
Long interspersed element-1 ribonucleoprotein particles protect telomeric ends in alternative lengthening of telomeres dependent cellsThomas Aschacher, Brigitte Wolf, Olivia Aschacher, et al.
British Journal of Cancer|September 4, 2015
Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkersRuth Exner, Walter Pulverer, Martina Diem, et al.
Ebiomedicine|October 2, 2015
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer PatientsDaniela Kandioler, Martina Mittlböck, Sonja Kappel, et al.
Human Mutation|March 26, 2003
Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in SlovakiaZdena Bartosova, Ivana Fridrichova, Maria Bujalkova, et al.
International Journal of Molecular Sciences|December 23, 2022
Impacts of Telomeric Length, Chronic Hypoxia, Senescence, and Senescence-Associated Secretory Phenotype on the Development of Thoracic Aortic AneurysmThomas Aschacher, Daniela Geisler, Verena Lenz, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Strategy for prevention of cancers of the esophagusJunichi Akiyama, Leo Alexandre, Anushka Baruah, et al.
Ebiomedicine|September 17, 2025
PNPLA3 polymorphism worsens chemotherapy associated liver injury and affects overall survival in colorectal cancer patients with liver metastasis undergoing hepatic resectionBenedikt Rumpf, Jonas Santol, Anna E Kern, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Chemistry|September 6, 2008
Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumorsMaria Bujalkova, Katarina Zavodna, Tomas Krivulcik, et al.
The Journal of General Virology|November 14, 2013
Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vectorIrina Kuznetsova, Anna-Polina Shurygina, Brigitte Wolf, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 20, 2014
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group studyDaniela Kandioler, Sebastian F Schoppmann, Ronald Zwrtek, et al.
Neoplasia (New York, N.Y.)|December 18, 2019
Long interspersed element-1 ribonucleoprotein particles protect telomeric ends in alternative lengthening of telomeres dependent cellsThomas Aschacher, Brigitte Wolf, Olivia Aschacher, et al.
British Journal of Cancer|September 4, 2015
Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkersRuth Exner, Walter Pulverer, Martina Diem, et al.
Ebiomedicine|October 2, 2015
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer PatientsDaniela Kandioler, Martina Mittlböck, Sonja Kappel, et al.
Human Mutation|March 26, 2003
Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in SlovakiaZdena Bartosova, Ivana Fridrichova, Maria Bujalkova, et al.
International Journal of Molecular Sciences|December 23, 2022
Impacts of Telomeric Length, Chronic Hypoxia, Senescence, and Senescence-Associated Secretory Phenotype on the Development of Thoracic Aortic AneurysmThomas Aschacher, Daniela Geisler, Verena Lenz, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Strategy for prevention of cancers of the esophagusJunichi Akiyama, Leo Alexandre, Anushka Baruah, et al.
Ebiomedicine|September 17, 2025
PNPLA3 polymorphism worsens chemotherapy associated liver injury and affects overall survival in colorectal cancer patients with liver metastasis undergoing hepatic resectionBenedikt Rumpf, Jonas Santol, Anna E Kern, et al.
Pageof 3